Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Rodriguez

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Rheumatology (Oxford, England)|June 14, 2022
Interstitial lung disease in ANCA-associated vasculitis: associated factors, radiographic features and mortalityBrett Doliner, Karen Rodriguez, Sydney B Montesi, et al.
The Permanente Journal|April 19, 2013
Ingestion of magnetic toys: report of serious complications requiring surgical intervention and a proposed management algorithmJerry Tsai, Donald B Shaul, Roman M Sydorak, et al.
The American Journal of Gastroenterology|May 15, 2025
Recycling in Ambulatory Gastrointestinal Endoscopy, A Single Center ExperienceImmanuel K Ho, Daniel V Carr, Mary S Coniglio, et al.
The Journal of Biological Chemistry|July 13, 2006
Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor gammaRobert A Winn, Michelle Van Scoyk, Mandy Hammond, et al.
Oncology and Therapy|August 4, 2024
From Triple- to Penta-Exposed Multiple Myeloma: A Real-World Study in a Medicare PopulationThomas E Delea, Qiufei Ma, Glenn S Kroog, et al.
Biotechnology Journal|February 20, 2024
Amino acid degradation pathway inhibitory by-products trigger apoptosis in CHO cellsVerónica S Martínez, Karen Rodriguez, Timothy McCubbin, et al.
Future Oncology (London, England)|February 27, 2025
Patient preferences for triple-class-exposed relapsed or refractory multiple myeloma treatment: a discrete-choice studySikander Ailawadhi, Timothy J Inocencio, Carol Mansfield, et al.
Microbiome|October 17, 2025
Abundant and active acetogens enhance the carbon dioxide sink of Blue Carbon ecosystemsKaren Rodriguez, Francesco Ricci, Gaofeng Ni, et al.
Journal of Strength and Conditioning Research|May 10, 2018
Comparison of Psychological and Physiological Responses to Imposed vs. Self-selected High-Intensity Interval TrainingErin Kellogg, Cheyann Cantacessi, Olivia McNamer, et al.
Future Oncology (London, England)|December 1, 2025
A plain language summary of patient preferences for treatments for multiple myeloma that has relapsed or is refractory to prior therapySikander Ailawadhi, Timothy J Inocencio, Carol Mansfield, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Rheumatology (Oxford, England)|June 14, 2022
Interstitial lung disease in ANCA-associated vasculitis: associated factors, radiographic features and mortalityBrett Doliner, Karen Rodriguez, Sydney B Montesi, et al.
The Permanente Journal|April 19, 2013
Ingestion of magnetic toys: report of serious complications requiring surgical intervention and a proposed management algorithmJerry Tsai, Donald B Shaul, Roman M Sydorak, et al.
The American Journal of Gastroenterology|May 15, 2025
Recycling in Ambulatory Gastrointestinal Endoscopy, A Single Center ExperienceImmanuel K Ho, Daniel V Carr, Mary S Coniglio, et al.
The Journal of Biological Chemistry|July 13, 2006
Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor gammaRobert A Winn, Michelle Van Scoyk, Mandy Hammond, et al.
Oncology and Therapy|August 4, 2024
From Triple- to Penta-Exposed Multiple Myeloma: A Real-World Study in a Medicare PopulationThomas E Delea, Qiufei Ma, Glenn S Kroog, et al.
Biotechnology Journal|February 20, 2024
Amino acid degradation pathway inhibitory by-products trigger apoptosis in CHO cellsVerónica S Martínez, Karen Rodriguez, Timothy McCubbin, et al.
Future Oncology (London, England)|February 27, 2025
Patient preferences for triple-class-exposed relapsed or refractory multiple myeloma treatment: a discrete-choice studySikander Ailawadhi, Timothy J Inocencio, Carol Mansfield, et al.
Microbiome|October 17, 2025
Abundant and active acetogens enhance the carbon dioxide sink of Blue Carbon ecosystemsKaren Rodriguez, Francesco Ricci, Gaofeng Ni, et al.
Journal of Strength and Conditioning Research|May 10, 2018
Comparison of Psychological and Physiological Responses to Imposed vs. Self-selected High-Intensity Interval TrainingErin Kellogg, Cheyann Cantacessi, Olivia McNamer, et al.
Future Oncology (London, England)|December 1, 2025
A plain language summary of patient preferences for treatments for multiple myeloma that has relapsed or is refractory to prior therapySikander Ailawadhi, Timothy J Inocencio, Carol Mansfield, et al.
Pageof 5